Targeted gene delivery to the nervous system using herpes simplex virus vectors

Physiology and Behavior

Volumn 77, Issue 4-5, 2002, Pages 483-488

  Mata, Marina ^a,b   Glorioso, Joseph C ^a   Fink, David J ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c S 520 BST ^*  (United States)

Author keywords

Enkephalin; Gene therapy; Herpes simplex virus; Neuropathy; Neurotrophic factor; Pain

Indexed keywords

NEUROTROPHIC FACTOR; OPIATE PEPTIDE; PROENKEPHALIN; VIRUS VECTOR;

ARTICLE; GENE DELIVERY SYSTEM; GENE TRANSFER; HERPES SIMPLEX VIRUS; LABORATORY; MOLECULAR BIOLOGY; NERVE ENDING; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE; SPINAL CORD NERVE CELL; SPINAL GANGLION; VIRUS RECOMBINANT;

EID: 12244306216     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(02)00908-3     Document Type: Article

References (21)

1. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature. 407:2000;802-809.
2. Apfel S.C. Neurotrophic factor therapy-prospects and problems. Clin. Chem. Lab. Med. 39:2001;351-355.
3. Apfel S.C. Is the therapeutic application of neurotrophic factors dead? Ann. Neurol. 51:2002;8-11.
4. Enna S.J., Coyle J.T. Pharmacological management of neurological and psychiatric disorders. 1998;McGraw-Hill, NY, St. Louis, San Francisco, Auckland, Bogota, Caracas, Lisbon, London, Madrid.
5. Roizman B., Sears A. Herpes simplex viruses and their replication. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B., Struass S.E. Fields virology. 1996;2231-2295 Lippincott-Raven, Philadelphia, PA.
6. Stevens J.G. Overview of herpes virus latency. Semin. Virol. 5:1994;191-196.
7. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular synthesis: I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:1974;8-19.
8. DeLuca N.A., McCarthy A.M., Schaffer P.A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
9. Sacks W.R., Greene C.C., Aschman D.P., Schaffer P.A. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55:1985;796-805.
10. McCarthy A.M., McMahan L., Schaffer P.A. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63:1989;18-27.
11. Samaniego L., Webb A., DeLuca N. Functional interaction between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J. Virol. 69:1995;5705-5715.
12. Ozuer A., Wechuck J.B., Goins W.F., Wolfe D., Glorioso J.C., Ataai M.M. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol. Bioeng. 77:2002;685-692.
13. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. PNAS. 96:1999;4078-4083.
14. Natsume A., Mata M., Goss J., Huang S., Wolfe D., Oligino T.et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp. Neurol. 169:2001;231-238.
15. Natsume A., Mata M., Wolfe D., Oligino T., Goss J., Huang S.et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma. 19:2002;61-68.
16. Yamada M., Natsume A., Mata M., Oligino T., Goss J., Glorioso J.et al. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp. Neurol. 168:2001;225-230.
17. Mata M., Zhang M., Hu X., Fink D.J. HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J. Neurovirol. 7:2001;476-480.
18. Chattopadhyay M., Wolfe D., Huang S., Goss J., Glorioso J., Fink D. In vivo gene therapy of pyridoxine-induced neuropathy by HSV-mediated gene transfer of neurotrophin-3. Ann. Neurol. 51:2002;19-27.
19. Goss J.R., Goins W.F., Lacomis D., Mata M., Glorioso J.C., Fink D.J. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neruropathy in streptozotocin-induced diabetes in the mouse. Diabetes. 51:2002;2227-2232.
20. Goss J.R., Mata M., Goins W.F., Wu H.H., Glorioso J.C., Fink D.J. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8:2001;551-556.
21. Goss JR, Harley CF, Mata M, O'Malley ME, Goins WF, Hu X-P, et al. Herpes vector-mediated expression of proenkephalin reduces pain-related behavior in a model of bone cancer pain. Ann. Neurol. [in press].